While the company maintained its full-year revenue guidance, it lowered EBIT margins to negative 41% at the midpoint, from negative 28% previously, "to invest in lead-gen, engineering talent, and version upgrades for customers - largely aimed at capturing the GenAI opportunity," the analyst stated. Needham On C3.ai Analyst Mike Cikos maintained a Hold rating on the stock. C3.ai's subscription revenues accelerated again from 8% in the previous quarter to 12% year-on-year, Cikos said. "Furthermore, Subscription Revenue beat the consensus, adding $5.1 million dollars sequentially," he added. "Management spoke to multiple positive leading indicators including accelerating growth in Customer Engagements and Consumption Pilots," the analyst further stated. AI Price Action: Shares of C3.ai lost 10.77% Thursday, closing at $26.02. Photo via Pixabay.